Dr Reddys Laboratories (RDY) Other Non-Current Liabilities (2009 - 2026)

Dr Reddys Laboratories has reported Other Non-Current Liabilities for 18 years, with the latest figure at $31.9 million in Q2 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 21.59% year-over-year to $31.9 million in Q2 2026; TTM through Jun 2026 was $31.9 million, a 21.59% decrease from a year earlier, with the FY2026 full-year figure at $378.1 billion, up 12.97% from the prior year.
• Other Non-Current Liabilities was $31.9 million for Q2 2026 at Dr Reddys Laboratories, down from $37.7 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $71.9 million in Q3 2024, with the low at $26.3 million in Q4 2025.
• Average Other Non-Current Liabilities over 5 years is $41.6 million, with a median of $37.9 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities soared 67.5% in 2024, then plunged 62.42% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $36.2 million in 2022, then surged by 39.11% to $50.3 million in 2023, then surged by 39.24% to $70.1 million in 2024, then slumped by 62.42% to $26.3 million in 2025, then rose by 20.98% to $31.9 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $31.9 million (Q2 2026), $37.7 million (Q1 2026), and $26.3 million (Q4 2025), per Business Quant data.